Daniel Peterlik

506 total citations
27 papers, 417 citations indexed

About

Daniel Peterlik is a scholar working on Rheumatology, Immunology and Behavioral Neuroscience. According to data from OpenAlex, Daniel Peterlik has authored 27 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 11 papers in Immunology and 9 papers in Behavioral Neuroscience. Recurrent topics in Daniel Peterlik's work include Spondyloarthritis Studies and Treatments (12 papers), Stress Responses and Cortisol (9 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). Daniel Peterlik is often cited by papers focused on Spondyloarthritis Studies and Treatments (12 papers), Stress Responses and Cortisol (9 papers) and Rheumatoid Arthritis Research and Therapies (9 papers). Daniel Peterlik collaborates with scholars based in Germany, Switzerland and United States. Daniel Peterlik's co-authors include Peter J. Flor, Nicole Uschold‐Schmidt, Stefan O. Reber, Dominic Schmidt, Anja Lechner, Daniela N. Männel, Andrea M. Füchsl, Markus Fendt, Ivo Vranesic and Herman van der Putten and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Annals of the Rheumatic Diseases.

In The Last Decade

Daniel Peterlik

25 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Daniel Peterlik Germany 11 173 157 131 107 62 27 417
Pamela W. L. Yeh United States 9 198 1.1× 77 0.5× 87 0.7× 51 0.5× 42 0.7× 12 490
Г. В. Идова Russia 13 215 1.2× 175 1.1× 160 1.2× 221 2.1× 80 1.3× 72 520
Helen J. Chen United States 11 66 0.4× 54 0.3× 122 0.9× 64 0.6× 54 0.9× 15 368
Krzysztof Kucia Poland 13 76 0.4× 113 0.7× 111 0.8× 220 2.1× 22 0.4× 44 501
Liz Weber Switzerland 6 87 0.5× 127 0.8× 78 0.6× 189 1.8× 154 2.5× 6 416
M Morán United States 6 150 0.9× 192 1.2× 48 0.4× 60 0.6× 174 2.8× 10 533
Arata Oh‐Nishi Japan 13 114 0.7× 61 0.4× 232 1.8× 179 1.7× 51 0.8× 28 621
Emmanuel Cruz United States 11 177 1.0× 64 0.4× 132 1.0× 39 0.4× 29 0.5× 13 453
Ana Cicvaric Austria 11 84 0.5× 58 0.4× 109 0.8× 78 0.7× 61 1.0× 22 355
DS Jessop United Kingdom 13 200 1.2× 234 1.5× 83 0.6× 32 0.3× 136 2.2× 21 563

Countries citing papers authored by Daniel Peterlik

Since Specialization
Citations

This map shows the geographic impact of Daniel Peterlik's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Peterlik with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Peterlik more than expected).

Fields of papers citing papers by Daniel Peterlik

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniel Peterlik. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Peterlik. The network helps show where Daniel Peterlik may publish in the future.

Co-authorship network of co-authors of Daniel Peterlik

This figure shows the co-authorship network connecting the top 25 collaborators of Daniel Peterlik. A scholar is included among the top collaborators of Daniel Peterlik based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniel Peterlik. Daniel Peterlik is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vodenčarević, Asmir, Peter Kästner, Michaela Köhm, et al.. (2025). Predicting Treatment Outcomes in Patients With Psoriatic Arthritis or Axial Spondyloarthritis: An Artificial Intelligence–Driven Approach. The Journal of Rheumatology. 53(2). 152–161.
2.
Rudwaleit, Martín, Frank Behrens, Christopher T. Ritchlin, et al.. (2025). Uveitis in patients with axial spondyloarthritis or psoriatic arthritis: a post hoc analysis from placebo-controlled phase III studies with secukinumab. Therapeutic Advances in Musculoskeletal Disease. 17. 1759720X251340255–1759720X251340255.
3.
Peterlik, Daniel, et al.. (2024). POS0199 HOW DOES AGE AFFECT THE SAFETY PROFILE IN SPONDYLOARTHRITIS PATIENTS TREATED WITH SECUKINUMAB IN REAL WORLD? DATA FROM THE GERMAN AQUILA STUDY. Annals of the Rheumatic Diseases. 83. 347–347. 1 indexed citations
4.
5.
Kiltz, Uta, PP Sfikakis, Éric Lespessailles, et al.. (2022). POS1053 LONG-TERM RETENTION, EFFECTIVENESS AND SAFETY OF SECUKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS OR ANKYLOSING SPONDYLITIS: RESULTS FROM THE OBSERVATIONAL SERENA STUDY. Annals of the Rheumatic Diseases. 81. 846–847. 1 indexed citations
6.
7.
8.
9.
10.
Peterlik, Daniel, et al.. (2019). Metabotropic glutamate receptor subtype 7 controls maternal care, maternal motivation and maternal aggression in mice. Genes Brain & Behavior. 19(1). e12627–e12627. 5 indexed citations
11.
Peterlik, Daniel, Anna Bludau, Dominic Schmidt, et al.. (2016). Blocking metabotropic glutamate receptor subtype 5 relieves maladaptive chronic stress consequences. Brain Behavior and Immunity. 59. 79–92. 14 indexed citations
12.
Iacovelli, Luisa, Luisa Di Menna, Daniel Peterlik, et al.. (2016). Type-7 metabotropic glutamate receptors negatively regulate α1-adrenergic receptor signalling. Neuropharmacology. 113(Pt A). 343–353. 3 indexed citations
13.
Schmidt, Dominic, Daniel Peterlik, Stefan O. Reber, Anja Lechner, & Daniela N. Männel. (2016). Induction of Suppressor Cells and Increased Tumor Growth following Chronic Psychosocial Stress in Male Mice. PLoS ONE. 11(7). e0159059–e0159059. 48 indexed citations
14.
Langgartner, Dominik, Daniel Peterlik, Sandra Foertsch, et al.. (2016). Individual differences in stress vulnerability: The role of gut pathobionts in stress-induced colitis. Brain Behavior and Immunity. 64. 23–32. 59 indexed citations
15.
Peterlik, Daniel, Peter J. Flor, & Nicole Uschold‐Schmidt. (2015). The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders. Current Neuropharmacology. 14(5). 514–539. 39 indexed citations
16.
Gee, Christine E., Daniel Peterlik, Rochdi Bouhelal, et al.. (2014). Blocking Metabotropic Glutamate Receptor Subtype 7 (mGlu7) via the Venus Flytrap Domain (VFTD) Inhibits Amygdala Plasticity, Stress, and Anxiety-related Behavior. Journal of Biological Chemistry. 289(16). 10975–10987. 64 indexed citations
17.
Fendt, Markus, Stefan Imobersteg, Daniel Peterlik, et al.. (2013). Differential roles of mGlu7 and mGlu8 in amygdala-dependent behavior and physiology. Neuropharmacology. 72. 215–223. 33 indexed citations
18.
Uschold‐Schmidt, Nicole, Daniel Peterlik, Andrea M. Füchsl, & Stefan O. Reber. (2013). HPA axis changes during the initial phase of psychosocial stressor exposure in male mice. Journal of Endocrinology. 218(2). 193–203. 20 indexed citations
19.
20.
Schmidt, Dominic, Stefan O. Reber, Catherine Botteron, et al.. (2010). Chronic psychosocial stress promotes systemic immune activation and the development of inflammatory Th cell responses. Brain Behavior and Immunity. 24(7). 1097–1104. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Pamela W. L. Yeh Breakdown of academic impact, for papers by Г. В. Идова Breakdown of academic impact, for papers by Helen J. Chen Breakdown of academic impact, for papers by Krzysztof Kucia Breakdown of academic impact, for papers by Liz Weber Breakdown of academic impact, for papers by M Morán Breakdown of academic impact, for papers by Arata Oh‐Nishi Breakdown of academic impact, for papers by Emmanuel Cruz Breakdown of academic impact, for papers by Ana Cicvaric Breakdown of academic impact, for papers by DS Jessop
Rankless by CCL
2026